Galmed Pharmaceuticals Ltd. Adjourns Annual General Meeting Due to Lack of Quorum
2025-10-28SEC Filing 6-K (0001493152-25-019879)
Galmed Pharmaceuticals Ltd. convened its Annual General Meeting of Shareholders on October 28, 2025. However, the meeting was adjourned for one day to the same time and place due to a lack of quorum. The meeting will be reconvened on October 29, 2025, at 4:00 p.m. Israel time at the offices of Meitar | Law Offices, the legal counsel to the Company, located at 16 Abba Hillel Silver Rd., Ramat Gan, 5250608, Israel. This Form 6-K is incorporated by reference into the Company’s Registration Statements on Form S-8 (Registration Nos. 333-206292, 333-227441, 333-284163, and 333-290399) and the Company’s Registration Statement on Form F-3 (Registration Nos. 333-272722 and 333-283241).
Tickers mentioned in this filing:GLMD
The link to the original SEC document:https://www.sec.gov/Archives/edgar/data/1595353/0001493152-25-019879.txt